Reimbursement Rates for Calendar Year 2023, 12387-12388 [2023-03896]
Download as PDF
<![CDATA[
12387
Federal Register / Vol. 88, No. 38 / Monday, February 27, 2023 / Notices
working over a period of 12 months,
alternating between Learning Sessions
in which teams come together to learn
about the chosen topic and to plan
changes, and Action Periods in which
the teams return to their respective
organizations and test those changes in
their clinic settings. The domains for the
proposed CoPs are trauma informed
care, pre-conception counseling, and
youth transitioning into adult HIV care
services.
Need and Proposed Use of the
Information: Process and outcome
evaluations are a critical part of
ensuring that CoP initiatives were
implemented as planned and met their
intended outcome. Evaluation of
technical assistance (TA) depends on
establishing clear goals and plans from
the beginning of the process. This
includes specifying the intended impact
of the TA with concrete, measurable
objectives. To judge performance against
goals, HRSA will administer TA
evaluation surveys following TA and
training, webinars, teleconferences, and
meetings. Findings will drive quality
improvement activities and reports.
The evaluation plan focuses on
process and impact evaluation of all
CoP Teams (Pre-Conception Counseling
and Sexual Health, Trauma-Informed
Care, and Transitioning Adolescents to
Adult Care) over the duration of the 4year period of performance. The
evaluation plan components will be
operationalized to include TA
satisfaction measures (reaction), change
in knowledge after the TA (learning),
and change in behavior or practice after
the introduction of evidence-based
interventions (behavior). More
specifically, the evaluation plan
includes (1) post TA satisfaction
measures, (2) pre-post measures of CoP
staff knowledge about effective
practices, (3) retrospective measures to
gather measures of CoP staff knowledge
for the first community of practice only,
and (4) measures of TA usefulness and
impact on CoP performance.
Likely Respondents: Up to 90 RWHAP
Part D Women, Infant, Children, Youth
recipients will participate in the CoPs.
Each recipient may have up to six staff
members who may complete the survey.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Pre-conception Counseling Community of Practice Retrospective Pretest-Post Assessment .........................................................................
Community of Practice Pre-Assessment ...............................................
Community of Practice Post-Assessment .............................................
Community of Practice Session Assessment ........................................
Targeted and Intensive TA Assessment ...............................................
Foundational TA Assessment ................................................................
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
ddrumheller on DSK120RN23PROD with NOTICES
[FR Doc. 2023–03911 Filed 2–24–23; 8:45 am]
BILLING CODE 4165–15–P
Number of
responses per
respondent
20:06 Feb 24, 2023
Jkt 259001
90
180
180
1,620
120
150
.4733
.2900
.3767
.0767
.0833
.0616
42.6
52.2
67.8
124.3
10.0
9.2
990
........................
2,340
....................
306.1
Indian Health Service
RIN 0917–AA22
Reimbursement Rates for Calendar
Year 2023
Indian Health Service, HHS.
Notice.
AGENCY:
Notice is provided that the
Director of the Indian Health Service
(IHS) has approved the rates for
inpatient and outpatient medical care
provided by the IHS facilities for
Calendar Year 2023.
SUPPLEMENTARY INFORMATION:
SUMMARY:
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
Total
burden
hours
1
1
1
6
1
1
Background
The Director of the Indian Health
Service (IHS), under the authority of
sections 321(a) and 322(b) of the Public
Health Service Act (42 U.S.C. 248 and
249(b)), Public Law 83–568 (42 U.S.C.
VerDate Sep<11>2014
Average
burden per
response
(in hours)
90
180
180
270
120
150
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
ACTION:
Total
responses
2001(a)), and the Indian Health Care
Improvement Act (25 U.S.C. 1601 et
seq.), has approved the following rates
for inpatient and outpatient medical
care provided by IHS facilities for
Calendar Year 2023 for Medicare and
Medicaid beneficiaries, beneficiaries of
other federal programs, and for
recoveries under the Federal Medical
Care Recovery Act (42 U.S.C. 2651–
2653). The inpatient rates for Medicare
Part A are excluded from the table
below. That is because Medicare
inpatient payments for IHS hospital
facilities are made based on the
prospective payment system, or (when
IHS facilities are designated as Medicare
Critical Access Hospitals) on a
reasonable cost basis. Since the
inpatient per diem rates set forth below
do not include all physician services
and practitioner services, additional
payment shall be available to the extent
that those services are provided.
E:\FR\FM\27FEN1.SGM
27FEN1
12388
Federal Register / Vol. 88, No. 38 / Monday, February 27, 2023 / Notices
Inpatient Hospital per Diem Rate
(Excludes Physician/Practitioner
Services)
Calendar Year 2023
Lower 48 States $4,333
Alaska $3,478
Outpatient per Visit Rate (Excluding
Medicare)
Calendar Year 2023
Lower 48 States $654
Alaska $862
Outpatient per Visit Rate (Medicare)
Calendar Year 2023
Lower 48 States $620
Alaska $801
Medicare Part B Inpatient Ancillary per
Diem Rate
Calendar Year 2023
Lower 48 States $829
Alaska $1,066
Outpatient Surgery Rate (Medicare)
Established Medicare rates for
freestanding Ambulatory Surgery
Centers.
Effective Date for Calendar Year 2023
Rates
Consistent with previous annual rate
revisions, the Calendar Year 2023 rates
will be effective for services provided
on or after January 1, 2023, to the extent
consistent with payment authorities,
including the applicable Medicaid State
plan.
Roselyn Tso,
Director, Indian Health Service.
[FR Doc. 2023–03896 Filed 2–24–23; 8:45 am]
BILLING CODE 4165–16–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
ddrumheller on DSK120RN23PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Oral, Dental and Craniofacial
Sciences Study Section.
VerDate Sep<11>2014
20:06 Feb 24, 2023
Jkt 259001
Date: March 24, 2023.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Richard Michael Lovering,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1000J,
Bethesda, MD 20892, (301) 867–5309,
loveringrm@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: The Cancer Biotherapeutics
Development (CBD).
Date: March 27–28, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Melrose Hotel, 2430 Pennsylvania
Ave. NW, Washington, DC 20037.
Contact Person: Laurie Ann Shuman Moss,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 867–5309, laurie.shumanmoss@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Molecular Genetics and Genomics.
Date: March 27, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mollie Kim Manier, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–0510, mollie.manier@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Viral
Dynamics and Transmission.
Date: March 28–29, 2023.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sharon Isern, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 810J,
Bethesda, MD 20892, (301) 435–0000,
iserns2@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Immunity and Host Defense.
Date: March 28, 2023.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Deanna C Bublitz, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
20892, (301) 594–4005, deanna.bublitz@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Motor Control and Rehabilitation.
Date: March 28, 2023.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sara Louise Hargrave,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3170,
Bethesda, MD 20892, (301) 443–7193,
hargravesl@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR21–089
Specific Pathogen Free Macaque Colonies
(U42 Clinical Trial Not Allowed).
Date: March 28, 2023.
Time: 10:30 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Anthony Wing Sang Chan,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 809K,
Bethesda, MD 20892, (301) 496–9392,
chana3@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Biology of Aging and Infection.
Date: March 28, 2023.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jimok Kim, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6107 Rockledge Drive, Bethesda, MD
20892, (301) 402–8559, jimok.kim@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Epidemiology and Population
Health.
Date: March 28, 2023.
Time: 12:00 p.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lisa Tisdale Wigfall, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1007G,
Bethesda, MD 20892, (301) 594–5622,
wigfalllt@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Respiratory Sciences.
Date: March 29–30, 2023.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\27FEN1.SGM
27FEN1
]]>Agencies
[Federal Register Volume 88, Number 38 (Monday, February 27, 2023)]
[Notices]
[Pages 12387-12388]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-03896]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Indian Health Service
RIN 0917-AA22
Reimbursement Rates for Calendar Year 2023
AGENCY: Indian Health Service, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is provided that the Director of the Indian Health
Service (IHS) has approved the rates for inpatient and outpatient
medical care provided by the IHS facilities for Calendar Year 2023.
SUPPLEMENTARY INFORMATION:
Background
The Director of the Indian Health Service (IHS), under the
authority of sections 321(a) and 322(b) of the Public Health Service
Act (42 U.S.C. 248 and 249(b)), Public Law 83-568 (42 U.S.C. 2001(a)),
and the Indian Health Care Improvement Act (25 U.S.C. 1601 et seq.),
has approved the following rates for inpatient and outpatient medical
care provided by IHS facilities for Calendar Year 2023 for Medicare and
Medicaid beneficiaries, beneficiaries of other federal programs, and
for recoveries under the Federal Medical Care Recovery Act (42 U.S.C.
2651-2653). The inpatient rates for Medicare Part A are excluded from
the table below. That is because Medicare inpatient payments for IHS
hospital facilities are made based on the prospective payment system,
or (when IHS facilities are designated as Medicare Critical Access
Hospitals) on a reasonable cost basis. Since the inpatient per diem
rates set forth below do not include all physician services and
practitioner services, additional payment shall be available to the
extent that those services are provided.
[[Page 12388]]
Inpatient Hospital per Diem Rate (Excludes Physician/Practitioner
Services)
Calendar Year 2023
Lower 48 States $4,333
Alaska $3,478
Outpatient per Visit Rate (Excluding Medicare)
Calendar Year 2023
Lower 48 States $654
Alaska $862
Outpatient per Visit Rate (Medicare)
Calendar Year 2023
Lower 48 States $620
Alaska $801
Medicare Part B Inpatient Ancillary per Diem Rate
Calendar Year 2023
Lower 48 States $829
Alaska $1,066
Outpatient Surgery Rate (Medicare)
Established Medicare rates for freestanding Ambulatory Surgery
Centers.
Effective Date for Calendar Year 2023 Rates
Consistent with previous annual rate revisions, the Calendar Year
2023 rates will be effective for services provided on or after January
1, 2023, to the extent consistent with payment authorities, including
the applicable Medicaid State plan.
Roselyn Tso,
Director, Indian Health Service.
[FR Doc. 2023-03896 Filed 2-24-23; 8:45 am]
BILLING CODE 4165-16-P
